January 7, 2002 FYI MAD IN AMERICA (Perseus Press), a new book by Robert Whitaker, a prize winning science journalist, is sure to cause a stir. Whitaker holds psychiatry’s feet to the fire by examining the evidence in the professional psychiatric literature, FDA documents, published treatment outcome studies–including the World…
Studies Link Zyprexa to Diabetes & Deaths_Balt Sun Thu, 20 Mar 2003 Eli Lilly’s best selling drug, olanzapine (Zyprexa), originally approved for schizophrenia, then for bi-polar disorder, is prescribed widely. But the drug has been shown to produce early onset diabetes, severe hyperglycemia–and deaths. Adolescents and young adults appear to…
Text of AHRP Amicus Brief filed with the Maryland Court of Appeals in support of the Court’s ruling against Kennedy Krieger Institute for exposing children to lead poison in an experiment. The Court of Appeals Decision Validates AHRP’s Stand Against Using Children in Harmful Research Experiments.
Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP
To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration, Dockets Management Branch (HFA-305) Food and Drug Administration
Re: COMMENT ON: Docket #00N-0074 April 24, 2001 Interim Rule: "Additional Safeguards for Children in Clinical Investigations of FDA-Regulated Products
Excerpt: The FDA rightly chose not to permit the section 46.408 (c) waiver by IRBs of parental or guardian permission, as it leaves the specific circumstances for such a violation of parental rights to the discretion of local Institutional Review Boards (IRB). Given the stream of revelations of gross ethical and procedural violations at one after another of the nation’s premier research institutions, assumptions that “procedural safeguards are in place,” or that IRBs can be relied upon to make decisions that protect the best interests of human subjects – adults and children – has been debunked.
Washington Post_Harvesting China’s Blood_installment 4 December 20, 2000. Washington Post. In what is, so far, the most devastating installment in the Washington Post series about the unholly alliances that comprise the booming human research industry, America’s premier academic research center is shown–not only to have violated ethical research standards in…
Harvard-affiliated gene studies in China face federal inquiry – Boston Globe. August 1, 2000. Harvard-affiliated gene studies in China face federal inquiry, by Deborah Nelson. Genetic research in China is booming. The biotech industry, in collaboration with scientists from America’s elite research centers & the U.S. government, is looking at…
Is it ethical to expose healthy children to risks of drug- induced pathology on a speculative, unproven theory?
July 14, 2000. New FDA Warning about fatal risk linked to Melaril after 40 years! FYI For 40 years schizophrenia patients have been prescribed Mellaril, a drug that the FDA finally acknowledges causes sudden death due to cardiac arrest! Why did it take the FDA 40 years before it sent…
Chemically Induced Psychosis Experiments: An Inhumane Paradigm in Psychiatric Research Congressional Testimony submitted by Vera Sharav * February 2, 2000 Statement For the Record Submitted To U.S. Senate Sub-Committee: Public Health & Safety of the Senate Health, Education, Labor & Pensions Committee Hearing Our efforts helped bring to public attention…
Statement For the Record Submitted to
The U.S. Senate Sub-Committee: Public Health & Safety of the Senate Health, Education, Labor & Pensions Committee Hearing
Our efforts helped bring to public attention major medical ethics violations in Federally-funded research in which uninformed, vulnerable American citizens are put at high risks without justification. As a result, such individuals have often suffered severe consequences – some have lost their lives unnecessarily. Based on the evidence – including testimonies by families and patients – we believe five factors contribute to unethical human experiments:
For distribution: January, 2000
Although patients, families and the public were not informed – some would argue they were deceived – clinical psychiatrists and researchers have long known about severe adverse drug reactions (ADR) and disabling changes in the central nervous system in a high percentage of patients taking standard neuroleptic drugs.
Evidence of Neuroleptic Drug-Induced Brain Damage in Patients: A partial, Annotated Bibliography by Vera Hassner Sharav ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P New York, NY 10023 212-595-8974 FAX: 212-595-9086 e-mail: veracare@rcn.com For distribution: January, 2000 Although patients, families and the public were not informed…
